Home » Drug Safety News » FDA Warns Birth Control Maker Of Quality Issues

FDA Warns Birth Control Maker Of Quality Issues

Yet more problems in the Birth Control Industry, as we are getting word that the FDA has warned another drug maker about quality issues with their product.

According to several news reports, last month, the drugmaker Warner Chilcott, disclosed that the feds issued a subpoena for information on a wide array of sales and marketing activities. Now, the FDA has issued a warning letter suggesting quality problems have existed for the past five years with the Ovcon birth control pill.

The letter was prompted by an inspection last June of a Warner Chilcott plant in Puerto Rico. And the FDA notes the drugmaker did not thoroughly investigate the reason that certain lots of Ovcon failed stability testing going back to 2006. This can cause a problem with expiration dates. Meanwhile, Warner Chilcott continued to make Ovcon 50 tablets, even though these may have been subpotent.

In its defense, the drugmaker maintained that updated packaging should mitigate any degradation issues, but the FDA responded that a recent lot failed to comply with specifications and there was no documentation to support the assertion that the packaging change would make a difference. Moreover, the agency wrote there was no comprehensive effort to understand the problems.

To continue reading FDA Warns Birth Control Maker Of Quality Issues


1 Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Latest Tweets

Follow

Get every new post delivered to your Inbox.

%d bloggers like this: